Phase
Startup
TIGERQ
TIGERQ offers a full scope gene-editing analysis solution that combines proprietary sequencing algorithms in a SAAS solution for Pharma and Healthcare.
David Yudovich is a 4th year PhD student at Lund University and involved in the National Initiative on Stem Cells for Regenerative Therapy.
Did you know?
TIGERQ demonstrated 98% accuracy, 6-fold detection range increase, and drastic reduction of amplification error – and they’re just getting started!
New technologies for next-gen antibody therapeutics
Medicines for acute systemic inflammatory diseases
Cancer immunotherapies based in cell reprogramming
Introducing the fungal based industrial revolution
Automated microscopy image acquisition and analysis
Fighting iron deficiency
Implants of magnesium alloys
Developing future targeted immunotherapies in cancer
Digital service for patients
Ultrasound analysis for stroke risk assessment
Medical device that reduces pain during vein operation
Cloud-based solutions for genomics data
A reusable, user-friendly, and sustainable pregnancy test
Digital assistive device for post-surgical rehabilitation
Develops the first effective treatment for hypothyroidism
Builds gene therapy viral vectors
Early detection of pancreatic cancer
Bio-based vegan coating for fruits and vegetables
Equipment that improves the function of cultivated cells
Medtech solution for preventing pressure ulcers
Effective treatments for brain tumors
A new suturing choice for abdominal wall closure
Converting waste flows into valuable raw materials
Innovative systemic anti-inflammatory treatments
Safer medical needles for prostate biopsy
